Gliomas and the vascular fragility of the blood brain barrier
暂无分享,去创建一个
Vivaldo Moura-Neto | Emerson Leandro Gasparetto | J. Balça-Silva | S. Kahn | M. Lopes | E. Gasparetto | C. Righy | L. Campanati | E. Faveret | L. G. Dubois | Luiz Gustavo Dubois | Loraine Campanati | Cassia Righy | Isabella D’Andrea-Meira | Tania Cristina Leite de Sampaio e Spohr | Isabel Porto-Carreiro | Claudia Maria Pereira | Joana Balça-Silva | Suzana Assad Kahn | Marcos F. DosSantos | Marcela de Almeida Rabello Oliveira | Adriana Ximenes-da-Silva | Maria Celeste Lopes | Eduardo Faveret | M. DosSantos | C. Pereira | V. Moura-Neto | T. C. Spohr | A. Ximenes-da-Silva | I. Porto-Carreiro | Isabella D'andrea-Meira | Isabel Porto-Carreiro
[1] H. Sontheimer,et al. Expression and function of water channels (aquaporins) in migrating malignant astrocytes , 2007, Glia.
[2] Hyun Seok Song,et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier , 2003, Nature Medicine.
[3] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[4] M. Preusser,et al. Circulating biomarkers of CNS tumors: an update. , 2013, Biomarkers in medicine.
[5] M. Field,et al. The Effects of Histone Deacetylase Inhibitors on Glioblastoma-Derived Stem Cells , 2014, Journal of Molecular Neuroscience.
[6] Thomas Brinker,et al. Multiplicity of cerebrospinal fluid functions: New challenges in health and disease , 2008, Cerebrospinal Fluid Research.
[7] Luciana Romão,et al. Glioblastoma: therapeutic challenges, what lies ahead. , 2012, Biochimica et biophysica acta.
[8] R. Janzer,et al. Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.
[9] H. Wolburg,et al. An Allograft Glioma Model Reveals the Dependence of Aquaporin-4 Expression on the Brain Microenvironment , 2012, PloS one.
[10] Helios Klinikum. The Antitumorigenic Response of Neural Precursors Depends on Subventricular Proliferation and Age , 2008 .
[11] E. Kroh,et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.
[12] B. Barres,et al. Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.
[13] J. Duncan,et al. The choroid plexus-cerebrospinal fluid system: from development to aging. , 2005, Current topics in developmental biology.
[14] N. Kosaka,et al. Unraveling the Mystery of Cancer by Secretory microRNA: Horizontal microRNA Transfer between Living Cells , 2011, Front. Gene..
[15] Becky,et al. Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study. , 2000, Journal of neurosurgery.
[16] N. B. Viana,et al. Tenascin-C in the extracellular matrix promotes the selection of highly proliferative and tubulogenesis-defective endothelial cells. , 2011, Experimental cell research.
[17] M. Perretti,et al. Regulation of Leukocyte‐Endothelial Interactions by Glucocorticoids , 2002, Annals of the New York Academy of Sciences.
[18] H. Galla,et al. Control of the Blood–Brain Barrier by Glucocorticoids and the Cells of the Neurovascular Unit , 2009, Annals of the New York Academy of Sciences.
[19] J. Michálek,et al. MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications , 2011, Journal of cellular and molecular medicine.
[20] R. Spector. Nature and consequences of mammalian brain and CSF efflux transporters: four decades of progress , 2010, Journal of neurochemistry.
[21] M. C. Papadopoulos,et al. Molecular mechanisms of brain tumor edema , 2004, Neuroscience.
[22] Frans S S Leijten,et al. Electrocorticographic Discharge Patterns in Glioneuronal Tumors and Focal Cortical Dysplasia , 2006, Epilepsia.
[23] A. Meister,et al. [30] γ-Glutamyl transpeptidase , 1981 .
[24] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[25] R. Panizzutti,et al. Astrocyte-induced Synaptogenesis Is Mediated by Transforming Growth Factor β Signaling through Modulation of d-Serine Levels in Cerebral Cortex Neurons* , 2012, The Journal of Biological Chemistry.
[26] Benjamin Purow,et al. The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma? , 2011, Journal of Neuro-Oncology.
[27] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[28] Jan Claassen,et al. Treatment of status epilepticus: a survey of neurologists , 2003, Journal of the Neurological Sciences.
[29] P. Kelly,et al. Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.
[30] S. Pastorino,et al. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. , 2012, Neuro-oncology.
[31] K. P. Lehre,et al. The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction , 2010, Glia.
[32] A. Hirano,et al. Vascular structures in brain tumors. , 1975, Human pathology.
[33] Mitchel S Berger,et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. , 2008, Journal of neurosurgery.
[34] T. Ochiya,et al. The Impact of Extracellular Vesicle-Encapsulated Circulating MicroRNAs in Lung Cancer Research , 2014, BioMed research international.
[35] Y. Hayashi,et al. Regulation and function of aquaporin-1 in glioma cells. , 2007, Neoplasia.
[36] T. Hander,et al. A phase I trial of human corticotropin-releasing factor (hCRF) in patients with peritumoral brain edema. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[37] Peter Agre,et al. Aquaporin Water Channels , 2004, Proceedings of the American Thoracic Society.
[38] G. Reid,et al. Cell-free microRNAs: potential biomarkers in need of standardized reporting , 2013, Front. Genet..
[39] L. Svennerholm. Molecular neuropathology. , 1976, Progress in brain research.
[40] K. Vickers,et al. MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.
[41] Daniel H. Geschwind,et al. Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[42] Jing Liu,et al. Potential of cancer cell-derived exosomes in clinical application: a review of recent research advances. , 2014, Clinical therapeutics.
[43] X. Breakefield,et al. Brain Tumor Microvesicles: Insights into Intercellular Communication in the Nervous System , 2011, Cellular and Molecular Neurobiology.
[44] S. Kahn,et al. Microglial stress inducible protein 1 promotes proliferation and migration in human glioblastoma cells , 2012, Neuroscience.
[45] Shanquan Sun,et al. Expression of aquaporin8 in human astrocytomas: correlation with pathologic grade. , 2013, Biochemical and biophysical research communications.
[46] M. Bastin,et al. Effects of dexamethasone on peritumoural oedematous brain: a DT-MRI study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[47] Barbara Burwinkel,et al. Extracellular miRNAs: the mystery of their origin and function. , 2012, Trends in biochemical sciences.
[48] Hilla Peretz,et al. Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .
[49] R. Ransohoff,et al. Development, maintenance and disruption of the blood-brain barrier , 2013, Nature Medicine.
[50] L. Qin,et al. The molecular mechanism of dexamethasone-mediated effect on the blood–brain tumor barrier permeability in a rat brain tumor model , 2009, Neuroscience Letters.
[51] T. Vats,et al. Targeted Brain Tumor Treatment-Current Perspectives , 2007, Drug target insights.
[52] C. Iadecola. Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[53] E. Avignone,et al. Gap junctions and connexin expression in the normal and pathological central nervous system , 2002, Biology of the cell.
[54] H. Reulen,et al. A computed tomography study on formation, propagation, and resolution of edema fluid in metastatic brain tumors. , 1990, Advances in neurology.
[55] Xi Chen,et al. Identification of seven serum microRNAs from a genome‐wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas , 2013, International journal of cancer.
[56] P. Rakic,et al. Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. , 1997, Development.
[57] K. Kristensson,et al. Tryps and trips: cell trafficking across the 100-year-old blood–brain barrier , 2014, Trends in Neurosciences.
[58] E. Maiorano,et al. Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. , 1997, Ultrastructural pathology.
[59] John A Butman,et al. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] Hamid Cheshmi. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .
[61] M. Papadopoulos,et al. Aquaporin water channels in the nervous system , 2013, Nature Reviews Neuroscience.
[62] George C. Ebers,et al. The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability , 2010, Brain : a journal of neurology.
[63] H. Dvorak,et al. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. , 2003, The American journal of pathology.
[64] C. Iadecola,et al. Glial regulation of the cerebral microvasculature , 2007, Nature Neuroscience.
[65] R. Holmes,et al. p-(Chloromercuri)benzenesulfonate binding by membrane proteins and the inhibition of water transport in human erythrocytes. , 1986, Biochemistry.
[66] A. Vorbrodt,et al. Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist’s view , 2003, Brain Research Reviews.
[67] M. Rauh,et al. Dexamethasone Alleviates Tumor-Associated Brain Damage and Angiogenesis , 2014, PloS one.
[68] J. Antel,et al. Glial cell influence on the human blood‐brain barrier , 2001, Glia.
[69] R. Jain,et al. VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer , 2009, Nature Reviews Clinical Oncology.
[70] N. Chaverot,et al. Molecular Mechanism of Systemic Delivery of Neural Precursor Cells to the Brain: Assembly of Brain Endothelial Apical Cups and Control of Transmigration by CD44 , 2008, Stem cells.
[71] V. M. Neto,et al. Cerebellar astrocytes treated by thyroid hormone modulate neuronal proliferation , 1999, Glia.
[72] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[73] Abdelouahid Maghnouj,et al. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma. , 2012, Neuro-oncology.
[74] S. Liebner,et al. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme , 2000, Acta Neuropathologica.
[75] A. Maslov,et al. Neural Stem Cell Detection, Characterization, and Age- Related Changes in the Subventricular Zone of Mice , 2022 .
[76] F. Pfrieger,et al. Synaptic efficacy enhanced by glial cells in vitro. , 1997, Science.
[77] R. Keep,et al. A morphometric study on the development of the lateral ventricle choroid plexus, choroid plexus capillaries and ventricular ependyma in the rat. , 1990, Brain research. Developmental brain research.
[78] H. Kettenmann,et al. Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells. , 2010, Brain : a journal of neurology.
[79] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[80] C. Kruchko,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.
[81] W. Lukiw,et al. microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). , 2012, International journal of biochemistry and molecular biology.
[82] M. Mizoguchi,et al. Clinical implications of microRNAs in human glioblastoma , 2013, Front. Oncol..
[83] A. Álvarez-Buylla,et al. Interaction between astrocytes and adult subventricular zone precursors stimulates neurogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[84] Nathan McDannold,et al. Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system. , 2014, Advanced drug delivery reviews.
[85] T. Kielian. Glial connexins and gap junctions in CNS inflammation and disease , 2008, Journal of neurochemistry.
[86] S. Schwartz,et al. Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform. , 2013, Nanomedicine.
[87] S. Berntsson,et al. Epileptic seizures and survival in early disease of grade 2 gliomas , 2009, European journal of neurology.
[88] C. Miller,et al. Glioblastoma: Morphologic and molecular genetic diversity , 2007 .
[89] Robert C. Rostomily,et al. The cause of death in patients with glioblastoma is multifactorial: , 1991, Journal of Neuro-Oncology.
[90] I. R. Whittle,et al. The Pathogenesis of Tumour Associated Epilepsy , 2000, Acta Neurochirurgica.
[91] David J. Begley,et al. Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.
[92] J. Segovia,et al. Transmigration of Neural Stem Cells across the Blood Brain Barrier Induced by Glioma Cells , 2013, PloS one.
[93] E. Hedley‐Whyte,et al. Effect of dexamethasone on blood-brain barrier in the normal mouse. , 1986, Annals of neurology.
[94] S. Rosalki. Gamma-glutamyl transpeptidase. , 1975, Advances in clinical chemistry.
[95] E. Olson,et al. Toward microRNA-based therapeutics for heart disease: the sense in antisense. , 2008, Circulation research.
[96] C. Yun,et al. Levetiracetam Compared with Valproic Acid for the Prevention of Postoperative Seizures After Supratentorial Tumor Surgery: A Retrospective Chart Review , 2013, CNS Drugs.
[97] M. Taphoorn,et al. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. , 2013, Neuro-oncology.
[98] C. Nimsky,et al. Small interfering RNA–mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema , 2008, Nature Medicine.
[99] E. Goldmann. Die äussere und innere Sekretion des gesunden Organismus im Lichte der "vitalen Färbung" , 1909 .
[100] H. Kim,et al. Dexamethasone coordinately regulates angiopoietin-1 and VEGF: a mechanism of glucocorticoid-induced stabilization of blood-brain barrier. , 2008, Biochemical and biophysical research communications.
[101] Shinobu Ueda,et al. Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[102] M. Hristov,et al. Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection , 2009, Science Signaling.
[103] Gilberto Alves,et al. Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[104] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[105] K. Kim,et al. Human astrocytes/astrocyte-conditioned medium and shear stress enhance the barrier properties of human brain microvascular endothelial cells , 2007, Brain Research.
[106] E. Hedley‐Whyte,et al. Effect of dexamethasone on blood‐brain barrier in the normal mouse , 1986, Annals of neurology.
[107] M. C. Angulo,et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation , 2003, Nature Neuroscience.
[108] Graça Raposo,et al. Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.
[109] J. Melby,et al. Use of dexamethasone in treatment of cerebral edema associated with brain tumors. , 1961, The Journal-lancet.
[110] C. Hess,et al. Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects? , 2002, Supportive Care in Cancer.
[111] B. Knight. The Cause of Death , 1986, Journal of the Royal Society of Medicine.
[112] S. Booth,et al. Corticosteroid-use in primary and secondary brain tumour patients: a review , 2012, Journal of Neuro-Oncology.
[113] M. Deli. Blood-brain barrier models , 2007 .
[114] Ralph Weissleder,et al. In vivo tracking of neural progenitor cell migration to glioblastomas. , 2003, Human gene therapy.
[115] I. Blasig,et al. In Search of the Astrocytic Factor(s) Modulating Blood–Brain Barrier Functions in Brain Capillary Endothelial Cells In Vitro , 2005, Cellular and Molecular Neurobiology.
[116] S. Rüegg,et al. Brain Tumor and Seizures: Pathophysiology and Its Implications for Treatment Revisited , 2003, Epilepsia.
[117] Helena Borges,et al. Glioblastoma cells: a heterogeneous and fatal tumor interacting with the parenchyma. , 2011, Life sciences.
[118] V. M. Neto,et al. Neuro–glia interaction effects on GFAP gene: a novel role for transforming growth factor‐β1 , 2002, The European journal of neuroscience.
[119] K. Ishibashi,et al. [Aquaporin water channels]. , 1996, Nihon rinsho. Japanese journal of clinical medicine.
[120] Dongmei Sun,et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[121] E. Hansson,et al. Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.
[122] N. Abbott. Blood–brain barrier structure and function and the challenges for CNS drug delivery , 2013, Journal of Inherited Metabolic Disease.
[123] C. B. Trites. Epileptic seizures. , 1951, Canadian Medical Association journal.
[124] Hui Zhou,et al. MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion. , 2012, Neuro-oncology.
[125] F. Tovar-Moll,et al. Equinatoxin II potentiates temozolomide- and etoposide-induced glioblastoma cell death. , 2012, Current topics in medicinal chemistry.
[126] H. Kettenmann,et al. Tumor Young Investigator Award: tropism and antitumorigenic effect of endogenous neural precursors for gliomas. , 2006, Clinical neurosurgery.
[127] P. Keegan,et al. FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. , 2009, The oncologist.
[128] E. Goldmann. Neue Untersuchungen über die äussere und innere Sekretion des gesunden und kranken Organismus im Lichte der"vitalen Färbung" , 1912 .
[129] M. Gassmann,et al. Astrocytes and Pericytes Differentially Modulate Blood—Brain Barrier Characteristics during Development and Hypoxic Insult , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[130] P. Black,et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[131] Alan J. Wilson,et al. The blood-brain barrier: an important concept in neuroimaging. , 1994, AJNR. American journal of neuroradiology.
[132] E. Papavassiliou,et al. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. , 1996, The Journal of clinical investigation.
[133] T. Mikkelsen,et al. Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. , 2010, The oncologist.
[134] H. Lassmann,et al. Microglial cells are a component of the perivascular glia limitans , 1991, Journal of neuroscience research.
[135] Takahiro Ochiya,et al. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis , 2010, Cancer science.
[136] Graça Raposo,et al. Exosomes--vesicular carriers for intercellular communication. , 2009, Current opinion in cell biology.
[137] Alon Friedman,et al. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. , 2007, Brain : a journal of neurology.
[138] S. Strother,et al. The time course of steroid action on blood‐to‐brain and blood‐to‐tumor transport of 82Rb: A positron emission tomographic study , 1989, Annals of neurology.
[139] R. Michelucci,et al. Epilepsy in primary cerebral tumors: The characteristics of epilepsy at the onset (results from the PERNO study – Project of Emilia Romagna Region on Neuro‐Oncology) , 2013, Epilepsia.
[140] P. Cahill,et al. Influence of basolateral condition on the regulation of brain microvascular endothelial tight junction properties and barrier function , 2008, Brain Research.
[141] T. Takano,et al. Astrocyte-mediated control of cerebral blood flow , 2006, Nature Neuroscience.
[142] E. Mason. Cause of Death , 2007, Obesity surgery.
[143] Bethan Hughes,et al. 2008 FDA drug approvals , 2009, Nature Reviews Drug Discovery.
[144] C. Vecht,et al. Seizure prognosis in brain tumors: new insights and evidence-based management. , 2014, The oncologist.
[145] Suzana Herculano-Houzel,et al. The glia/neuron ratio: How it varies uniformly across brain structures and species and what that means for brain physiology and evolution , 2014, Glia.
[146] A. Vezzani,et al. Brain Inflammation in Epilepsy: Experimental and Clinical Evidence , 2005, Epilepsia.
[147] B. Barres,et al. Induction of Astrocyte Differentiation by Endothelial Cells , 2001, The Journal of Neuroscience.
[148] P. Cancilla,et al. gamma-Glutamyl transpeptidase in isolated brain endothelial cells: induction by glial cells in vitro. , 1980, Science.
[149] U. Gimsa,et al. Immune Privilege as an Intrinsic CNS Property: Astrocytes Protect the CNS against T-Cell-Mediated Neuroinflammation , 2013, Mediators of inflammation.
[150] G. Reifenberger,et al. Molecular Neuropathology of Gliomas , 2009, International journal of molecular sciences.
[151] H. Kettenmann,et al. Glioblastoma-Induced Attraction of Endogenous Neural Precursor Cells Is Associated with Improved Survival , 2005, The Journal of Neuroscience.
[152] Hiroshi Yamamoto,et al. Induction of various blood‐brain barrier properties in non‐neural endothelial cells by close apposition to co‐cultured astrocytes , 1997, Glia.
[153] L. Wilkins. The Epileptic Seizure , 1958, Neurology.
[154] T. Yamashita,et al. Molecular Therapeutic Targets for Glioma Angiogenesis , 2010, Journal of oncology.
[155] B. Kolls,et al. Phenytoin, Levetiracetam, and Pregabalin in the Acute Management of Refractory Status Epilepticus in Patients with Brain Tumors , 2012, Neurocritical Care.
[156] Maria K. Lehtinen,et al. The Cerebrospinal Fluid Provides a Proliferative Niche for Neural Progenitor Cells , 2011, Neuron.
[157] David N Louis,et al. Molecular pathology of malignant gliomas. , 2006, Annual review of pathology.
[158] N. Wu,et al. Circulating MicroRNAs: A Novel Class of Potential Biomarkers for Diagnosing and Prognosing Central Nervous System Diseases , 2013, Cellular and Molecular Neurobiology.
[159] S. Simões,et al. Design of peptide-targeted liposomes containing nucleic acids. , 2010, Biochimica et biophysica acta.